Sometimes the major annual medical meetings are jam-packed with
significant and market-moving data. And then sometimes they're like this
year's American College of Cardiology conference, with relatively
limited useful data from an investing perspective.
While there was some incremental data relating to significant
emerging growth markets like transcatheter valve replacement and renal
denervation, the most significant data concerns one of the more
uncertain market opportunities – left atrial appendage
occlusion/closure.
Please follow this link for more:
http://www.massdevice.com/blogs/massdevice/looking-back-pretty-sedate-acc?page=show
No comments:
Post a Comment